Sun Pharma Strikes $576M Deal to Get Hair Loss Drug to Rival Lilly, Pfizer Meds
Sun Pharmaceuticals is acquiring Concert Pharmaceuticals, a biotech whose lead program has positive data from two late-stage clinical trials in alopecia areata. The deal gives Sun Pharma a drug candidate that could match up against hair loss drugs from two big pharmaceutical companies.